SK11596A3 - A composition for the therapy of undepressed women suffer from hypothalamic amenorrhea - Google Patents

A composition for the therapy of undepressed women suffer from hypothalamic amenorrhea Download PDF

Info

Publication number
SK11596A3
SK11596A3 SK115-96A SK11596A SK11596A3 SK 11596 A3 SK11596 A3 SK 11596A3 SK 11596 A SK11596 A SK 11596A SK 11596 A3 SK11596 A3 SK 11596A3
Authority
SK
Slovakia
Prior art keywords
carbon atoms
alkyl
day
hydrogen
effective amount
Prior art date
Application number
SK115-96A
Other languages
English (en)
Slovak (sk)
Inventor
Gertrude V Upton
Albert T Derivan
Richard L Rudolph
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23502899&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SK11596(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by American Home Prod filed Critical American Home Prod
Publication of SK11596A3 publication Critical patent/SK11596A3/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SK115-96A 1995-01-30 1996-01-26 A composition for the therapy of undepressed women suffer from hypothalamic amenorrhea SK11596A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/380,903 US5506270A (en) 1995-01-30 1995-01-30 Venlafaxine in the treatment of hypothalamic amenorrhea in non-depressed women

Publications (1)

Publication Number Publication Date
SK11596A3 true SK11596A3 (en) 1997-05-07

Family

ID=23502899

Family Applications (1)

Application Number Title Priority Date Filing Date
SK115-96A SK11596A3 (en) 1995-01-30 1996-01-26 A composition for the therapy of undepressed women suffer from hypothalamic amenorrhea

Country Status (17)

Country Link
US (1) US5506270A (fr)
EP (1) EP0723779A1 (fr)
JP (1) JPH08231387A (fr)
KR (1) KR960028906A (fr)
CN (1) CN1137894A (fr)
AR (1) AR001074A1 (fr)
AU (1) AU703529B2 (fr)
CA (1) CA2167999A1 (fr)
CZ (1) CZ22996A3 (fr)
FI (1) FI956339A (fr)
HU (1) HUT75095A (fr)
IL (1) IL116935A0 (fr)
NO (1) NO955356L (fr)
NZ (1) NZ280744A (fr)
PE (1) PE13197A1 (fr)
SK (1) SK11596A3 (fr)
ZA (1) ZA9511038B (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6262115B1 (en) * 1995-05-22 2001-07-17 Alza Coporation Method for the management of incontinence
US5912268A (en) * 1995-05-22 1999-06-15 Alza Corporation Dosage form and method for treating incontinence
US20030215507A1 (en) * 1996-03-25 2003-11-20 Wyeth Extended release formulation
US6274171B1 (en) 1996-03-25 2001-08-14 American Home Products Corporation Extended release formulation of venlafaxine hydrochloride
US20060068017A1 (en) * 1996-03-25 2006-03-30 Wyeth Extended release formulation
US6342533B1 (en) * 1998-12-01 2002-01-29 Sepracor, Inc. Derivatives of (−)-venlafaxine and methods of preparing and using the same
HUP0200898A3 (en) * 1999-04-06 2005-09-28 Sepracor Inc Derivatives of venlafaxine and methods of preparing and using the same
US20020022662A1 (en) * 1999-06-15 2002-02-21 American Home Products Corporation Enantiomers of O-desmethyl venlafaxine
US20020035158A1 (en) * 1999-06-15 2002-03-21 American Home Products Corporation Enantiomers of N-desmethyl venlafaxine
US7291646B2 (en) * 1999-11-24 2007-11-06 Wyeth Ethers of O-desmethyl venlafaxine
US6348494B1 (en) 2000-11-21 2002-02-19 American Home Products Corporation Ethers of o-desmethyl venlafaxine
US6572890B2 (en) * 2000-01-13 2003-06-03 Osmotica Corp. Osmotic device containing venlafaxine and an anti-psychotic agent
FR2807753B1 (fr) * 2000-04-13 2002-06-07 Adir Nouveaux derives d'heterocycloalkylbenzocyclobutane et d'heteroarylbenzocyclobutane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP1864967A1 (fr) * 2001-02-12 2007-12-12 Wyeth Procédé de fabrication d'O-desméthyl-venlafaxine
UA77234C2 (en) * 2001-12-05 2006-11-15 Wyeth Corp Monohydrate of venlafaxine hydrochloride and methods for its preparation (variants)
US7030164B2 (en) * 2001-12-05 2006-04-18 Wyeth Crystalline polymorph of venlafaxine hydrochloride and methods for the preparation thereof
AU2003219117A1 (en) * 2002-03-28 2003-10-13 Synthon B.V. Extended release venlafaxine formulations
US6703044B1 (en) * 2002-10-25 2004-03-09 Dexcel Pharma Tech, Ltd Venlafaxine formulations
US20070077301A1 (en) * 2002-12-23 2007-04-05 Meyer Glenn A Venlafaxine osmotic device formulation
EP1523979A1 (fr) * 2003-10-13 2005-04-20 Wyeth Forme d'administration de libération prolongée
EP1523981A1 (fr) * 2003-10-13 2005-04-20 Wyeth Préparations à libération prolongée de la venlafaxine
AU2006265008A1 (en) * 2005-07-06 2007-01-11 Sepracor Inc. Combinations of eszopiclone and O-desmethylvenlafaxine, and methods of treatment of menopause and mood, anxiety, and cognitive disorders
EP1957470A1 (fr) * 2005-12-05 2008-08-20 Wyeth Procede pour la synthese selective d'enantiomeres de 1-(2-amino-1-phenyl-ethyl)-cyclohexanols substitues
US20080081067A1 (en) * 2006-10-03 2008-04-03 Gupta Manishkumar Sustained release pharmaceutical compositions of venlafaxine and process for preparation thereof
KR100965527B1 (ko) * 2008-05-08 2010-06-23 제일약품주식회사 신규(4-(2-(디메틸아미노)-1-(1-하이드록시사이클로헥실)에틸)페녹시)포스페이트 또는 이의 약학적으로 허용가능한 염,이의 제조방법 및 이를 유효성분으로 함유하는 중추신경계질환 예방 및 치료용 조성물

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4110438A (en) * 1977-03-21 1978-08-29 American Home Products Corporation Method of treating depression
US4291028A (en) * 1977-12-30 1981-09-22 Nichols Vorys Follicular phase estrogen or progestin with physiologic estrogen/progestin luteal phase replacement drug delivery system
US4292315A (en) * 1977-12-30 1981-09-29 Nichols Vorys Follicular phase estrogen or progestin with physiologic estrogen/progestin luteal phase replacement drug delivery system
US4328134A (en) * 1980-05-06 1982-05-04 Schally Andrew Victor Anorexigenic peptides
US4535186A (en) * 1983-04-19 1985-08-13 American Home Products Corporation 2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives
US4761501A (en) * 1983-10-26 1988-08-02 American Home Products Corporation Substituted phenylacetamides
US4611078A (en) * 1983-10-26 1986-09-09 American Home Products Corporation Substituted phenylacetonitriles
US4826844A (en) * 1987-09-30 1989-05-02 American Home Products Corporation Substituted 1-(aralkyl-piperazinoalkyl) cycloalkanols
TW344661B (en) * 1993-11-24 1998-11-11 Lilly Co Eli Pharmaceutical composition for treatment of incontinence

Also Published As

Publication number Publication date
NZ280744A (en) 2000-11-24
ZA9511038B (en) 1997-06-30
HU9503922D0 (en) 1996-03-28
AR001074A1 (es) 1997-09-24
AU703529B2 (en) 1999-03-25
FI956339A0 (fi) 1995-12-29
CN1137894A (zh) 1996-12-18
JPH08231387A (ja) 1996-09-10
EP0723779A1 (fr) 1996-07-31
CZ22996A3 (en) 1996-09-11
HUT75095A (en) 1997-04-28
CA2167999A1 (fr) 1996-07-31
AU4075295A (en) 1996-08-08
NO955356D0 (no) 1995-12-29
KR960028906A (ko) 1996-08-17
PE13197A1 (es) 1997-04-22
IL116935A0 (en) 1996-05-14
NO955356L (no) 1996-07-31
FI956339A (fi) 1996-07-31
US5506270A (en) 1996-04-09

Similar Documents

Publication Publication Date Title
SK11596A3 (en) A composition for the therapy of undepressed women suffer from hypothalamic amenorrhea
EP0639374B1 (fr) Nouveaux traitements utilisant des dérivés phenéthyle
US5902830A (en) Use of droloxifene for the treatment of cardiovascular disease
CA2205134C (fr) Procedes de traitement de cephalees vasculaires
US5530013A (en) Venlafaxine in the inducement of cognition enhancement
US20040019101A1 (en) Methods of treating gastrointestinary and genitourinary pain disorders
JP2003534375A (ja) 選択性抗エストロゲン薬を用いた男性におけるアンドロゲン欠乏症の治療法
US5708036A (en) Method of treating premature uterine contractions using the optically active R(-)-isomer of albuterol
JPH0585932A (ja) Ｉ型糖尿病治療薬
US20030036556A1 (en) Zonisamide use in headache
AU643487B2 (en) Use of optically pure s(-) atenolol for the treatment of cardiovascular disorders
SK155994A3 (en) Using of benzo/g/ quinolines
US4241087A (en) Dysmenorrhea treatment
US5854248A (en) Nefazodone: use in migraine prophylaxis
Page et al. Drugs in the management of hypertension. Part II
EP0667150B1 (fr) Venlafaxine et ses analogues pour induire une amélioration des fonctions cognitives
Adams Adrenergic agonists and antagonists
JP2610735B2 (ja) 抗鬱剤および抗ストレス剤組成物
IE903867A1 (en) Use of arylalkylamides in the treatment of neurodegenerative¹diseases
US6121328A (en) Racemic propranolol
KR920003580B1 (ko) 동맥경화증 예방 및 치료제
AU744990B2 (en) New treatment using phenethylamine derivatives
JPH02233680A (ja) ５ｈｔ↓２受容体の選択的遮断剤
FR2579894A1 (fr)
WO1990003168A1 (fr) Procede de modification du comportement alimentaire